Medindia
Medindia LOGIN REGISTER
Advertisement

Access Pharmaceuticals Provides Update on MuGard Commercial Activities

Tuesday, May 17, 2011 General News
Advertisement
MuGard Prescriptions Ramping; Ongoing Positive Clinical Experience in Radiation Oncology and Medical Oncology; Demand Necessitates Initiation of Significantly Larger Second Commercial Manufacturing Run
Advertisement

Contact: Company

Contact: Investor Relations

Christine Berni

Donald C. Weinberger/Diana Bittner (media)

Director of Investor Relations

Wolfe Axelrod Weinberger Assoc. LLC

Access Pharmaceuticals, Inc.

(212) 370-4500

(212) 786-6208

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close